Rare diseases
Investigational molecules
Locations
705 conditions with trials, the busiest first
3 901 trials across Europe, recruiting first
Study on Talazoparib for Advanced Breast Cancer Patients Using the RECAP Test
The NetherlandsStudy on the Effect of Intensive Chemotherapy with FOLFOXIRI Compared to Standard Treatment for Patients with Localized Colon Cancer
SpainStudy on Pentaglobin for Treating Fever in Acute Leukemia or Stem Cell Transplant Patients with Resistant Bacteria
ItalyStudy on Pembrolizumab and Cyclophosphamide for Patients with Metastatic Urothelial Cancer
ItalyStudy of BI-1607, Ipilimumab, and Pembrolizumab for Patients with Advanced Melanoma
GermanyStudy on the Safety and Effectiveness of ALPHA1H for Adults with Non-Muscle Invasive Bladder Cancer Awaiting Tumor Removal Surgery
CzechiaStudy of CD19-CAR_Lenti, Fludarabine, and Cyclophosphamide in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia or Aggressive B-Cell Lymphomas
ItalyStudy of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
AustriaStudy on Improving Oral Cancer Surgery Using cRGD-ZW800-1 Fluorescent Imaging for Patients with Oral Cancer
The NetherlandsStudy on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients
The NetherlandsStudy of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment
DenmarkStudy of AGuIX Nanoparticles and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma
FranceThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
